Sun Pharma and Sun Pharma Advanced Research Co. (SPARC) have inked a licensing agreement for the commercialization of benzyl alcohol and propylene glycol-free phenobarbital sodium powder for injection ...
Sun Pharmaceutical Industries Ltd on Wednesday launched its phenobarbital sodium injection, SEZABY for treatment of neonatal seizures in the US. SEZABY is the first and only product approved by the US ...
Sun Pharma and Sun Pharma Advanced Research obtained the Food and Drug Administration’s nod for Sezaby (phenobarbital sodium powder for injection) for the treatment of neonatal seizures. Sezaby is the ...